Barclays maintains an 'Overweight' on Deere (DE); Q2 Preview - Expecting Upward Guidance
Get Alerts DE Hot Sheet
Price: $608.85 -0.58%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Deere (NYSE: DE) price target of $101.00.
Analyst, Andy Kaplowitz, said, "Deere remains one of our preferred Machinery names ahead of its FY2Q earnings report this week, and while expectations seem relatively high into the quarter, we think the company is poised to report a generally solid result and outlook."
Kaplowitz currently sees Q2 EPS at $2.45 (vs. consensus of $2.53), but believes the company will top estimates and modestly raise full year earnings guidance.
For an analyst ratings summary and ratings history on Deere click here. For more ratings news on Deere click here.
Shares of Deere closed at $79.07 yesterday.
Analyst, Andy Kaplowitz, said, "Deere remains one of our preferred Machinery names ahead of its FY2Q earnings report this week, and while expectations seem relatively high into the quarter, we think the company is poised to report a generally solid result and outlook."
Kaplowitz currently sees Q2 EPS at $2.45 (vs. consensus of $2.53), but believes the company will top estimates and modestly raise full year earnings guidance.
For an analyst ratings summary and ratings history on Deere click here. For more ratings news on Deere click here.
Shares of Deere closed at $79.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share